The RDH12 gene helps the retina, the light sensing tissue at the back of the eye, process chemicals related to vitamin A and limit cell damage. If this gene does not work well, retinal cells can wear down over time, which may lead to early vision loss, trouble seeing in dim light, and inherited eye conditions that gradually affect sight. This gene plays an important role in keeping the eye’s light detecting cells healthy.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage activities in the body. Certain genes provide the code for proteins, which do much of the cell’s everyday work. Others are used mainly to regulate when a process happens, where it happens, and how active it is. Taken together, genes affect how your body develops and functions, and they can also influence how you respond to food, stress, or medications. More detail on this topic is available in the LearnHub.
Overview
RDH12Gene function
What if the gene works
In the retina, the RDH12 gene helps recycle vitamin A related molecules needed for vision. It also helps clear harmful byproducts in light sensing cells, supporting retinal health over time.
Risk
What if the gene does not work
Variants in the RDH12 gene can cause inherited retinal disease, often with night blindness, reduced side vision, and worsening central vision. Milder and more severe variants can influence when vision problems begin and how quickly they progress.
Treatment
What does that mean for your treatment
No treatment or drug choice based specifically on the RDH12 gene is currently established for people with a pathogenic variant in the RDH12 gene. The RDH12 gene is being studied as a target for gene-based therapies in inherited retinal conditions, but this work remains experimental and is not yet part of routine care.
Conditions associated with RDH12
Gene function
What if the gene works
Seeing in changing light depends on steady vitamin A handling inside the retina. In the eye’s light sensing cells, the RDH12 gene helps manage vitamin A related molecules and supports cleanup after daily light exposure. Understanding how the RDH12 gene works in the retina can make it easier to see how retinal cells stay healthy during everyday vision.
The RDH12 gene helps light sensing cells convert retinal into retinol, two forms of vitamin A your eyes use every day. This keeps vitamin A compounds moving in a controlled way inside the retina.
After your eyes take in light, some vitamin A byproducts need further handling inside light sensing cells. RDH12 helps process these compounds as part of how the retina manages the chemistry of seeing.
RDH12 also helps clear reactive aldehydes (highly active chemical byproducts) that can build up during normal eye activity. This protective role supports the day to day health of retinal cells, especially during regular light exposure.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal differences among people, including appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
RDH12 gene variants can make the protein unstable, reduce its enzyme activity, or stop cells from making a full-length protein. Milder variants may leave some activity, while more severe variants often cause near-complete loss of function and greater stress inside retinal cells. In people with RDH12-related retinal disease, that difference in remaining activity can influence how early vision problems begin and how marked they become.
How variants are linked to conditions
Pathogenic variants in the RDH12 gene cause inherited retinal conditions that usually begin in infancy or childhood. The clearest link between RDH12 gene variants and eye disease is with severe early-onset retinal dystrophy, including Leber congenital amaurosis, a severe vision condition that starts very early in life. Some people with variants in the RDH12 gene are diagnosed with retinitis pigmentosa or cone-rod retinal dystrophy.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For RDH12, risk is mainly shaped by genetics: people usually develop related eye disease only if they inherit two changed copies of the RDH12 gene, one from each parent. There is not broadly confirmed evidence that diet, exercise, or other lifestyle factors change the chance of developing an RDH12-related condition.
Inheritance of RDH12 variants
Most RDH12-related eye conditions follow an autosomal recessive inheritance pattern. This means a child inherits one RDH12 variant from each parent, and the parents are often healthy carriers. When both parents carry an RDH12 variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither. In practical terms, the RDH12 inheritance pattern usually means it can affect brothers and sisters in the same family even when earlier generations were not affected.
What does my RDH12 result mean for my family?
For many living with an RDH12-related eye condition, the family meaning depends on the exact result. Most well-known RDH12 conditions happen when both parents are healthy carriers, so brothers and sisters may also be affected or be carriers. A smaller number of RDH12 changes can act in a dominant way, where a parent or child may also carry the same change, so the family picture can differ by variant.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the RDH12 gene, doctors use genetic testing for RDH12 variants on a blood or saliva sample. A lab reads the DNA sequence to look for variants linked with inherited retinal conditions. Results may confirm a diagnosis, clarify carrier status, or help show whether a variant was inherited.
When should I consider getting a genetic test?
Genetic testing for the RDH12 gene may be worth considering if someone has vision loss that starts in infancy, childhood, or the teen years, especially with night blindness or a family history of an inherited eye condition. It can help clarify whether RDH12 is part of the cause and support diagnosis and family planning.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains depends on the condition and the specific type of variant involved. Over time, many factors such as lifestyle, environment, age, and medical history also influence how the body functions. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most useful when considered together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same medication works well for one person, has less effect in another, or causes more side effects in someone else. Small inherited differences can change how the body breaks down a drug, moves it through the body, or responds to it at its target, and this kind of variation is common.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medication. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect either how strongly a drug works or how the body handles it. This information can support more informed, more personalized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the RDH12 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how someone will respond to medicines. General questions about medications, side effects, or supplements are best discussed with your doctor or pharmacist.
History
RDH12 entered the genetics literature in the early 2000s during a period of rapid progress in finding genes linked to inherited retinal conditions. Researchers identified variants in the RDH12 gene in families affected by early-onset severe retinal disease, including forms of Leber congenital amaurosis. From these first observations, research expanded steadily, and RDH12 became recognized as one of several genes involved in childhood retinal degeneration. As more families were studied in different countries, doctors learned that changes in this gene could be associated with a range of eye findings rather than one fixed pattern. That growing history helped improve genetic diagnosis and sharpened the way inherited retinal conditions are classified.